Literature DB >> 3110285

Structural analysis of an HLA-B27 population variant, B27f. Multiple patterns of amino acid changes within a single polypeptide segment generate polymorphism in HLA-B27.

S Rojo, P Aparicio, S Y Choo, J A Hansen, J A López de Castro.   

Abstract

The structure of a new HLA-B27 variant, B27f, distinguishable from other HLA-B27 subtypes by isoelectric focusing and serologic criteria, has been established by comparative peptide mapping and radiochemical sequence analysis. HLA-B27f differs from the major B27.1 subtype in three clustered amino acid replacements: Asp74, Asp77, and Leu81 in B27.1 are changed to Tyr74, Asn77, and Ala81, respectively in B27f. This pattern of differences is analogous to that of HLA-B27.2 in that this subtype also differs from B27.1 in multiple clustered substitutions within the same segment. Thus, polymorphism within the HLA-B27 system is being achieved by introducing different sets of amino acid changes within a particular short segment of the alpha 1 domain. The most likely mechanism for the introduction of multiple changes within this segment is a nonreciprocal recombination event, such as gene conversion. The structural analogies and ethnic distribution of B27f and B27.2 as compared with those of B27.3, and B27.4 support a dynamic model of HLA-B27 evolution in which polymorphism has been created after the separation of the major ethnic groups. In this model, a Caucasian branch would be characterized by subtypes differing from B27.1 in a few changes within the alpha 1 domain, which were probably generated by single genetic steps. An Oriental branch would include those subtypes which differ from B27.1 by changes in both alpha 1 and alpha 2, involving multiple genetic steps for their generation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110285

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Molecular typing of HLA-B27 alleles.

Authors:  O Dominguez; E Coto; E Martinez-Naves; S Y Choo; C López-Larrea
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Nomenclature for factors of the HLA system, 1989. The WHO Nomenclature Committee.

Authors: 
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Molecular analysis of HLA-A2.4 functional variant KLO: close structural and evolutionary relatedness to the HLA-A2.2 subtype.

Authors:  N Doménech; R Castaño; E Goulmy; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51.

Authors:  M Sekimata; H Hayashi; S Nakayama; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Structural analysis of HLA-A2.4 functional variant KNE. Implications for the mapping of HLA-A2-specific T-cell epitopes.

Authors:  N Doménech; A Ezquerra; R Castaño; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody.

Authors:  J A Trapani; S Mizuno; S H Kang; S Y Yang; B Dupont
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  Nomenclature for factors of the HLA system, 1987.

Authors: 
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

8.  Nature of polymorphism in HLA-A, -B, and -C molecules.

Authors:  P Parham; C E Lomen; D A Lawlor; J P Ways; N Holmes; H L Coppin; R D Salter; A M Wan; P D Ennis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis.

Authors:  C M Higgins; T Lund; M E Shipley; A Ebringer; M Sadowska-Wroblewska; R K Craig
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

10.  In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.

Authors:  J D Taurog; F A el-Zaatari
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.